|
|
|
|
|
|
|
|
|
Exhibit 99.3
|
PFIZER INC |
||||||||||||
|
SEGMENT/PRODUCT REVENUES |
||||||||||||
|
THIRD QUARTER 1999 |
||||||||||||
|
(millions of dollars) |
||||||||||||
|
***********QUARTER-TO-DATE************ |
||||||||||||
|
WORLDWIDE |
U.S. |
INTERNATIONAL |
||||||||||
|
1999 |
1998 |
% |
1999 |
1998 |
% |
1999 |
1998 |
% |
||||
|
TOTAL REVENUES |
6,746 |
5,753 |
17 |
4,107 |
3,455 |
19 |
2,639 |
2,298 |
15 |
|||
|
PHARMACEUTICALS |
5,375 |
4,471 |
20 |
3,441 |
2,851 |
21 |
1,934 |
1,620 |
19 |
|||
|
TOTAL HUMAN PHARMACEUTICALS |
4,945 |
4,069 |
22 |
3,219 |
2,658 |
21 |
1,726 |
1,411 |
22 |
|||
|
- CARDIOVASCULAR DISEASES |
2,280 |
1,783 |
28 |
1,380 |
1,104 |
25 |
900 |
679 |
33 |
|||
|
LIPITOR |
995 |
578 |
72 |
730 |
427 |
71 |
265 |
151 |
75 |
|||
|
NORVASC |
778 |
662 |
17 |
358 |
335 |
7 |
420 |
327 |
28 |
|||
|
CARDURA |
195 |
172 |
13 |
90 |
85 |
5 |
105 |
87 |
21 |
|||
|
ACCUPRIL/ACCURETIC |
135 |
120 |
12 |
73 |
63 |
15 |
62 |
57 |
9 |
|||
|
PROCARDIA XL |
122 |
187 |
(35) |
122 |
187 |
(35) |
0 |
0 |
--- |
|||
|
- INFECTIOUS DISEASES |
751 |
752 |
--- |
434 |
432 |
--- |
317 |
320 |
(1) |
|||
|
ZITHROMAX |
224 |
189 |
18 |
170 |
138 |
23 |
54 |
51 |
4 |
|||
|
DIFLUCAN |
246 |
225 |
9 |
115 |
111 |
4 |
131 |
114 |
14 |
|||
|
VIRACEPT |
112 |
134 |
(16) |
112 |
107 |
5 |
0 |
27 |
(100) |
|||
|
TROVAN |
(8) |
41 |
--- |
(2) |
41 |
--- |
(6) |
0 |
--- |
|||
|
- CENTRAL NERVOUS SYSTEM |
845 |
702 |
20 |
675 |
567 |
19 |
170 |
135 |
26 |
|||
|
ZOLOFT |
520 |
480 |
8 |
416 |
394 |
6 |
104 |
86 |
21 |
|||
|
NEURONTIN |
237 |
132 |
79 |
207 |
113 |
84 |
30 |
19 |
52 |
|||
|
ARICEPT* |
23 |
15 |
49 |
0 |
0 |
--- |
23 |
15 |
49 |
|||
|
- DIABETES |
211 |
249 |
(15) |
202 |
241 |
(16) |
9 |
8 |
10 |
|||
|
GLUCOTROL XL |
68 |
57 |
19 |
65 |
55 |
18 |
3 |
2 |
45 |
|||
|
REZULIN |
134 |
181 |
(26) |
133 |
181 |
(26) |
1 |
0 |
274 |
|||
|
- ALLERGY |
144 |
119 |
21 |
143 |
117 |
22 |
1 |
2 |
(15) |
|||
|
ZYRTEC |
143 |
117 |
22 |
142 |
115 |
22 |
1 |
2 |
(15) |
|||
|
- VIAGRA |
245 |
138 |
77 |
158 |
112 |
40 |
87 |
26 |
239 |
|||
|
- ALLIANCE REVENUE (Aricept |
183 |
15 |
M+ |
169 |
17 |
913 |
14 |
(2) |
--- |
|||
|
- CAPSUGEL |
97 |
85 |
14 |
43 |
39 |
12 |
54 |
46 |
16 |
|||
|
- ANIMAL HEALTH |
333 |
317 |
5 |
179 |
154 |
16 |
154 |
163 |
(5) |
|||
|
CONSUMER PRODUCTS |
1,371 |
1,282 |
7 |
666 |
604 |
10 |
705 |
678 |
4 |
|||
|
- CONSUMER HEALTH CARE |
626 |
573 |
9 |
402 |
362 |
11 |
224 |
211 |
6 |
|||
|
- CONFECTIONERY PRODUCTS |
481 |
470 |
2 |
165 |
162 |
2 |
316 |
308 |
3 |
|||
|
- SHAVING PRODUCTS |
212 |
193 |
10 |
77 |
60 |
29 |
135 |
133 |
1 |
|||
|
- TETRA |
52 |
46 |
12 |
22 |
20 |
11 |
30 |
26 |
13 |
|||
* - Represents direct sales under license agreement with Eisai Co., Ltd.
M+ - Change greater than one thousand percent.
Restated to reflect the merger with Warner-Lambert Company in June 2000, which was accounted for as a pooling of interests.
Certain amounts and percentages may reflect rounding adjustments.
Certain prior year data have been reclassified to conform to the current year presentation.
|
|